A research team led by MedUni Vienna has investigated AC102, a new active substance that offers hope of an effective treatment for acute sudden hearing loss. The latest results have been published in the journal Cell Death & Disease. Initial findings from preclinical trials could represent a significant advancement in the treatment of acute hearing disorders.
Active substance shows promise for treating acute sudden hearing loss in animal models
